99) and rtN238T (0.71%) related with low sensitivity to adefovir (ADV), and the other two displayed variants, such as rtA211T (0.57%), rtQ215H (3.91%), rtA219S (13.32%), rtA223T (0.71) and rtA223S (0.46%), likely related to ADV. Conclusions: After more than 7 years’ complete viral suppression and despite find more relative reductions in HBsAg level, none of the 7 HBeAg-ve patients cleared HBsAg after discontinuing TDF. After TDF, there is an increase in HBV reverse transcriptase variability mainly due to variants with low sensitivity to ADV, which seems to reflect

a cross-resistance mechanism between ADV and TDF. This phenomenon could reflect evolutive pressure of TDF over the cccDNA reservoir during suppression of detectable viral replication. Study funded by Instituto de Salud Carlos III, grant PI 1 1/01973, co-financed by the European Regional Development Fund (ERDF). Disclosures:

Maria Buti – Advisory Committees or Review Panels: Boerhinger selleck Inghelm, Boer-hinger Inghelm; Speaking and Teaching: MSD, Bristol-Myers Squibb, Novartis, Gilead, Janssen, MSD, Bristol-Myers Squibb, Novartis, Gilead, Janssen Rafael Esteban – Speaking and Teaching: MSD, BMS, Novartis, Gilead, Glaxo, MSD, BMS, Novartis, Gilead, Glaxo, Janssen The following people have nothing to disclose: David Tabernero, Francisco Rodriguez-Frias, Rosario Casillas, Josep Gregori, Carolina Gonzalez, Irene Bel-monte Mula, Maria Homs, Maria Blasi, Josep Quer, Leonardo Nieto, Silvia Camos, selleck screening library Andrea Caballero We recently reported that despite antiviral treatment, HBV ccc DNA persists in hepatocellular carcinoma (HCC) and is correlated to the absence of vascular invasion. The tumoral (T) and non-tumoral(NT) liver transcriptomes

are now available. Patients and methods. 63 HBsAg-positive patients ( anti-HCV, anti-HDV and anti-HIV negative), resected for HCC. Most were cirrhotic (82% of cases) with low viremia under antiviral therapy (79%). Replication in T and NT was assessed by detection of full length HBV DNA, quantification of HBV ccc DNA or of total HBV DNA. Agilent micro arrays were used for transcriptomic experiments. Results. HBV ccc DNA was strongly correlated with transcriptome analysis. Principal component analysis (PCA) comparing differential gene expression between T and NT demonstrated in the first dimension, a clustering according to the tumoral vascular invasion and in the second dimension, a clustering according to the detection of HBV ccc DNA in T. Fatty acid metabolism, complement and coagulation, retinol metabolism and PPAR pathways were upregulated in absence of vascular invasion. Vascular smooth muscle contraction, ECM-receptor interaction and Gap junction pathways were upregulated in case of tumoral replication of HBV. Comparisons with other data on HCC showed in HCC not replicating HBV, an enrichment of genes related to vascular invasion. Conclusion. HBV replication in the HCC correlated to unfrequent vascular invasion, better prognosis and specific pathways.